Multicentricity in resected occult bronchogenic squamous cell carcinoma

Area of Science:

• Thoracic Surgery
• Oncology
• Pulmonology

Background:

• Multicentricity in lung cancer presents unique challenges for treatment and prognosis.
• Understanding the incidence and progression of multiple primary lung cancers is vital for patient management.

Purpose of the Study:

• To investigate the frequency and treatment outcomes of multicentric bronchogenic squamous cell carcinoma.
• To determine the cumulative rates and incidence of synchronous and metachronous multiple primary lung cancers.
• To compare survival rates between solitary and multicentric lung cancer cases.

Main Methods:

• Retrospective analysis of 127 patients with resected roentgenographically occult bronchogenic squamous cell carcinoma.
• Calculation of cumulative rates and incidence of second and third primary lung cancers.
• Evaluation of treatment outcomes (resection, laser, radiation) for metachronous cases.

Main Results:

• The 5-year cumulative rate for third primary lung cancer was 0.47, significantly higher than for second primary lung cancer (0.17).
• Synchronous multiple primary lung cancer patients had no recurrence but some developed subsequent cancers.
• Metachronous cases showed recurrence with resection (1/6) and laser/radiation therapy (2/4).
• Five-year survival rates were 0.90 for solitary and 0.59 for multicentric lung cancer.

Conclusions:

• Multicentric bronchogenic squamous cell carcinoma carries a substantial risk of developing subsequent primary lung cancers.
• Treatment strategies for metachronous disease require further investigation to optimize outcomes.
• Multicentricity significantly impacts overall survival compared to solitary lung cancer.